Trials / Terminated
TerminatedNCT04749797
Cranial Blocks for Postoperative Anesthesia
Randomized Study Of Cranial Blocks For Postoperative Anesthesia To Reduce Pain And Postoperative Opioid Usage
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study compares the standard of care to the standard of care plus the administration of bupivacaine or liposomal bupivacaine in patients receiving craniotomies.
Detailed description
Objective: To assess the effectiveness of analgesia by scalp nerve block with various agents in the first 72 hours following elective craniotomy. The investigators will employ a randomized, single-blinded, prospective study design. Participants will be randomized 1:1:1 into one of three treatment groups: Bupivacaine, Liposomal Bupivacaine, and Saline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Liposomal bupivacaine | Used as cranial block for craniotomy surgery |
| DRUG | Bupivacaine Injection | Used as cranial block for craniotomy surgery |
| DRUG | Saline | Used as cranial block for craniotomy surgery |
Timeline
- Start date
- 2020-09-02
- Primary completion
- 2021-07-20
- Completion
- 2021-07-20
- First posted
- 2021-02-11
- Last updated
- 2023-09-13
- Results posted
- 2023-09-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04749797. Inclusion in this directory is not an endorsement.